2016 Vol.34, N°2 - Table of contents
March-April 2016
One year in review
CER9361
2016,34,2
Pg. 0161-0171
Free to view
One year in review 2016: Sjögren’s syndrome
F. Ferro, R. Vagelli, C. Bruni, G. Cafaro, E. Marcucci, E. Bartoloni, C. Baldini
F. Ferro, R. Vagelli, C. Bruni, G. Cafaro, E. Marcucci, E. Bartoloni, C. Baldini
Full Papers
CER7913
2016,34,2
Pg. 0172-0183
Free to view
Disease-modifying anti-rheumatic drug use in pregnant women with rheumatic diseases: a systematic review of the risk of congenital malformations
C. Baldwin, A. Avina-Zubieta, S.K. Rai, E. Carruthers, M.A. De Vera
C. Baldwin, A. Avina-Zubieta, S.K. Rai, E. Carruthers, M.A. De Vera
CER8140
2016,34,2
Pg. 0184-0190
Free to view
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety
F. Heldmann, X. Baraliakos, U. Kiltz, J. Brandt, I.E. Van der horst-Bruinsma, R. Landewé, J. Sieper, G.R. Burmester, F. Van Den Bosch, K. De Vlam, H. Gaston, M. Gruenke, M. Witt, T. Appelboom, P. Emery, M. Dougados, M. Leirisalo-Repo, M. Breban, J. Braun
F. Heldmann, X. Baraliakos, U. Kiltz, J. Brandt, I.E. Van der horst-Bruinsma, R. Landewé, J. Sieper, G.R. Burmester, F. Van Den Bosch, K. De Vlam, H. Gaston, M. Gruenke, M. Witt, T. Appelboom, P. Emery, M. Dougados, M. Leirisalo-Repo, M. Breban, J. Braun
CER8295
2016,34,2
Pg. 0191-0199
Free to view
Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapy
F. Maas, A. Spoorenberg, E. Brouwer, A.M. Schilder, R.N. Chaudhry, F. Wink, H. Bootsma, E. Van Der Veer, S. Arends
F. Maas, A. Spoorenberg, E. Brouwer, A.M. Schilder, R.N. Chaudhry, F. Wink, H. Bootsma, E. Van Der Veer, S. Arends
CER8445
2016,34,2
Pg. 0200-0206
Free to view
A multidimensional ‘path analysis’ model of factors explaining fatigue in rheumatoid arthritis
S.A. Rongen-Van dartel, H. Repping-Wuts, R. Donders, D. Van Hoogmoed, H. Knoop, G. Bleijenberg, P.L. Van Riel, J. Fransen
S.A. Rongen-Van dartel, H. Repping-Wuts, R. Donders, D. Van Hoogmoed, H. Knoop, G. Bleijenberg, P.L. Van Riel, J. Fransen
CER8510
2016,34,2
Pg. 0207-0213
Free to view
Parvovirus infection in early arthritis
M. Mauermann, K. Hochauf-Stange, A. Kleymann, K. Conrad, M. Aringer
M. Mauermann, K. Hochauf-Stange, A. Kleymann, K. Conrad, M. Aringer
CER8787
2016,34,2
Pg. 0214-0221
Free to view
Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS
I. Essers, S. Ramiro, C. Stolwijk, M. Blaauw, R. Landewé, D. Van Der Heijde, F. Van Den Bosch, M. Dougados, A. Van Tubergen
I. Essers, S. Ramiro, C. Stolwijk, M. Blaauw, R. Landewé, D. Van Der Heijde, F. Van Den Bosch, M. Dougados, A. Van Tubergen
CER8683
2016,34,2
Pg. 0222-0229
Free to view
Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients
H. Hulejová, O. Kryštůfková, H. Mann, M. Klein, K. Pavlíčková, J. Zámečník, J. Vencovský, L. Šenolt
H. Hulejová, O. Kryštůfková, H. Mann, M. Klein, K. Pavlíčková, J. Zámečník, J. Vencovský, L. Šenolt
CER8735
2016,34,2
Pg. 0230-0235
Free to view
Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis
B. Tejera-Segura, A.M. De vera-González, R. López-Mejías, M.A. González-Gay, I. Ferraz-Amaro
B. Tejera-Segura, A.M. De vera-González, R. López-Mejías, M.A. González-Gay, I. Ferraz-Amaro
CER8737
2016,34,2
Pg. 0236-0241
Free to view
Genetic variants associated with rheumatoid arthritis patients and serotypes in European populations
O. Ruiz-Larrañaga, M. Uribarri, M.C. Alcaro, S. Escorza-Treviño, J. Del Amo, M. Iriondo, C. Manzano, P. Migliorini, V. Lóránd, A. Estonba
O. Ruiz-Larrañaga, M. Uribarri, M.C. Alcaro, S. Escorza-Treviño, J. Del Amo, M. Iriondo, C. Manzano, P. Migliorini, V. Lóránd, A. Estonba
CER8542
2016,34,2
Pg. 0242-0246
Free to view
Active immunisation targeting soluble murine tumour necrosis factor alpha is safe and effective in collagen-induced arthritis model treatment
J.H. Sun, Y.H. Zhang, J.Y. Kuang, G. Liu, Y.X. Liu, B.H. Liu
J.H. Sun, Y.H. Zhang, J.Y. Kuang, G. Liu, Y.X. Liu, B.H. Liu
CER8236
2016,34,2
Pg. 0247-0253
Free to view
The Italian Observational Study on Severe Osteoporosis (ISSO): 24-month results on incidence of fractures and adherence to treatment
L. Idolazzi, D. Maugeri, S. Monti, M. Massarotti, G. Osella, M. Barbagallo, R. Del Fiacco, S. Silvestri
on behalf of the ISSO Study Group
L. Idolazzi, D. Maugeri, S. Monti, M. Massarotti, G. Osella, M. Barbagallo, R. Del Fiacco, S. Silvestri
on behalf of the ISSO Study Group
CER8732
2016,34,2
Pg. 0254-0260
Free to view
Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease
G. Filippou, A. Adinolfi, M.A. Cimmino, C.A. Scirè, S. Carta, S. Lorenzini, P. Santoro, L.M. Sconfienza, I. Bertoldi, V. Picerno, V. Di Sabatino, P. Ferrata, M. Galeazzi, B. Frediani
G. Filippou, A. Adinolfi, M.A. Cimmino, C.A. Scirè, S. Carta, S. Lorenzini, P. Santoro, L.M. Sconfienza, I. Bertoldi, V. Picerno, V. Di Sabatino, P. Ferrata, M. Galeazzi, B. Frediani
CER8761
2016,34,2
Pg. 0261-0269
Free to view
Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era
G. Galicia-Hernández, F. Parra-Salcedo, P. Ugarte-Martínez, I. Contreras-Yáñez, A. Ponce-De-León, V. Pascual-Ramos
G. Galicia-Hernández, F. Parra-Salcedo, P. Ugarte-Martínez, I. Contreras-Yáñez, A. Ponce-De-León, V. Pascual-Ramos
CER8966
2016,34,2
Pg. 0270-0275
Free to view
Rheumatoid arthritis patients undergoing total hip and knee arthroplasty have better in-hospital outcomes compared with non-rheumatoid arthritis patients
H. Yoshihara, D. Yoneoka, A. Margalit, J.D. Zuckerman
H. Yoshihara, D. Yoneoka, A. Margalit, J.D. Zuckerman
CER8806
2016,34,2
Pg. 0276-0281
Free to view
A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritis
P. Tejón, I. Morante, I. Cabezas, C. Sarasqueta, P. Coto, R. Queiro
P. Tejón, I. Morante, I. Cabezas, C. Sarasqueta, P. Coto, R. Queiro
CER8525
2016,34,2
Pg. 0282-0290
Free to view
Identifying candidate genes involved in osteoarthritis through bioinformatics analysis
X. Zhang, Z. Yuan, S. Cui
X. Zhang, Z. Yuan, S. Cui
CER8676
2016,34,2
Pg. 0291-0295
Free to view
Predictors of health-related quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension
H. Wang, X. Guo, J. Lai, Q. Wang, Z. Tian, Y. Liu, M. Li, J. Zhao, X. Zeng, Q. Fang
H. Wang, X. Guo, J. Lai, Q. Wang, Z. Tian, Y. Liu, M. Li, J. Zhao, X. Zeng, Q. Fang
CER8633
2016,34,2
Pg. 0296-0302
Free to view
Association of spinal degenerative disc disease with thyroid autoimmunity
A. Shrestha, H.W. Cohen, C.E. Tagoe
A. Shrestha, H.W. Cohen, C.E. Tagoe
CER8733
2016,34,2
Pg. 0303-0310
Free to view
Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study
A. Saraux, S. Rouanet, R.-M. Flipo, J.-C. Poncet, P. Fardellone, P. Hilliquin, I. Idier, A. Cantagrel
A. Saraux, S. Rouanet, R.-M. Flipo, J.-C. Poncet, P. Fardellone, P. Hilliquin, I. Idier, A. Cantagrel
Brief Papers
CER8717
2016,34,2
Pg. 0311-0314
Free to view
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren’s syndrome: follow-up after the end of the phase II open-label BELISS study
L. Quartuccio, S. Salvin, L. Corazza, S. Gandolfo, M. Fabris, S. De Vita
L. Quartuccio, S. Salvin, L. Corazza, S. Gandolfo, M. Fabris, S. De Vita
Case Reports
CER8443
2016,34,2
Pg. 0315-0317
Free to view
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis
A.L. Fedele, S. Alivernini, E. Gremese, G. Ferraccioli
A.L. Fedele, S. Alivernini, E. Gremese, G. Ferraccioli
Review
CER8682
2016,34,2
Pg. 0318-0328
Free to view
The mechanism of action of tofacitinib – an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
J.A. Hodge, T.T. Kawabata, S. Krishnaswami, J.D. Clark, J.-B. Telliez, M.E. Dowty, S. Menon, M. Lamba, S. Zwillich
J.A. Hodge, T.T. Kawabata, S. Krishnaswami, J.D. Clark, J.-B. Telliez, M.E. Dowty, S. Menon, M. Lamba, S. Zwillich
CER8511
2016,34,2
Pg. 0329-0336
Free to view
Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis
J.-M. Berthelot, J. Sibilia
J.-M. Berthelot, J. Sibilia
Paediatric Rheumatology
CER8533
2016,34,2
Pg. 0337-0342
Free to view
IL-27 levels are low in enthesitis-related arthritis category of juvenile idiopathic arthritis
P. Gaur, R. Misra, A. Aggarwal
P. Gaur, R. Misra, A. Aggarwal
CER8486
2016,34,2
Pg. 0343-0351
Free to view
Features of childhood Sjögren's syndrome in comparison to adult Sjögren's syndrome: considerations in establishing child-specific diagnostic criteria
N. Yokogawa, S.M. Lieberman, D.D. Sherry, F.B. Vivino
N. Yokogawa, S.M. Lieberman, D.D. Sherry, F.B. Vivino
Letters to the Editor
CER8491
2016,34,2
Pg. 0352
Free to view
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors
E. Vizzardi, C. Bazzani, I. Cavazzana, E. Sciatti, I. Bonadei, F. Franceschini, A. Tincani, M. Metra
E. Vizzardi, C. Bazzani, I. Cavazzana, E. Sciatti, I. Bonadei, F. Franceschini, A. Tincani, M. Metra
CER8969
2016,34,2
Pg. 0353
Free to view
Anakinra long-term efficacy and safety in the management of Schnitzler’s syndrome and latent tuberculosis infection
G. Lopalco, A. Vitale, F. Iannone, L. Cantarini
G. Lopalco, A. Vitale, F. Iannone, L. Cantarini
CER8521
2016,34,2
Pg. 0354
Free to view
SAPHO and Mönckeberg’s sclerosis: two rare diseases and one patient
G. Famularo, F. Ceralli, F. Sensi, L. Gasbarrone, G. Minisola
G. Famularo, F. Ceralli, F. Sensi, L. Gasbarrone, G. Minisola
CER8808
2016,34,2
Pg. 0355-0356
Free to view
Rituximab-refractory lupus nephritis successfully treated with belimumab
C. Gonzalez-Echavarri, A. Ugarte, G. Ruiz-Irastorza
C. Gonzalez-Echavarri, A. Ugarte, G. Ruiz-Irastorza